28 March 2008
GM Statement
Eco Animal Health Group plc ("Eco" or the "Company")
Result of GM
The Board of Eco is pleased to announce that at the Company's General Meeting
held earlier today all of the resolutions were duly passed, including the
approval of a scrip dividend alternative and the placing of 10,526,316 new
ordinary shares at 100 pence per share to raise £10 million after expenses,
("the Placing").
Full details of the Placing were set out in a circular sent to shareholders on
11 March 2008. Application has been made for new ordinary shares issued
pursuant to the Placing to be admitted to trading on AIM and admission is
expected to occur on 31 March 2008 ('Admission').
Following the Placing and Admission of the new ordinary shares, the Company's
total voting rights will comprise of 45,125,043 ordinary shares of 5p each being
the issued share capital of the Company.
The above figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company, under the Disclosure
and Transparency Rules.
Peter Lawrence, (Chairman) has subscribed for 394,000 shares as part of the
Placing and following Admission he will control in aggregate a total of
approximately 22.05 per cent of the enlarged share capital.
Enquires:
Eco Animal Health Group plc
Peter Lawrence, Executive Chairman 020 8336 6190
Cenkos Securities plc
Stephen Keys / Liz Bowman 020 7397 8926
(Nominated Adviser)
ECO Animal Health Group plc is a leader in the development, registration and
marketing of pharmaceutical products. Our products for these global growth
markets promote well-being in animals. Our financial goals are achieved through
the careful and responsible application of science to generate value for our
shareholders.
Translate
